Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis
- 1 September 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cancer Causes & Control
- Vol. 17 (7), 889-899
- https://doi.org/10.1007/s10552-006-0035-5
Abstract
The inclusion of biomarkers measured on the continuous scale, such as endogenous sex hormones or antioxidant levels, has become common in epidemiologic studies, and introduces additional sources of error that are specific to biomarkers. This includes error associated with specimen collection, processing, and storage; laboratory error (both within and between batch); and variability in the biomarker levels over time within an individual. In this review, we discuss and recommend study design and analytic strategies to deal with these sources of measurement error. In particular we describe methods to prevent or minimize some sources of error through appropriate sample collection and storage, communication with the laboratory, proper batching of samples, and participant matching. We also discuss how to quantify error related to biomarkers, focusing on issues of quality control, pilot studies, and how to measure within-person stability over time. Further, we discuss analytic issues for dealing with laboratory and within-person variability. Finally we recommend that journals standardize the reporting of biomarker assays in scientific manuscripts.Keywords
This publication has 37 references indexed in Scilit:
- Endogenous Estrogen, Androgen, and Progesterone Concentrations and Breast Cancer Risk Among Postmenopausal WomenJNCI Journal of the National Cancer Institute, 2004
- Extraction/Chromatographic Testosterone RIA Can Be Used as the “Gold Standard” for Determining the Reliability of Direct Testosterone Immunoassay MeasurementsClinical Chemistry, 2004
- Plasma prolactin concentrations and risk of postmenopausal breast cancerCancer Research, 2004
- Insulin-like growth factors and neoplasiaNature Reviews Cancer, 2004
- Endogenous Sex Hormones and Breast Cancer in Postmenopausal Women: Reanalysis of Nine Prospective StudiesJNCI Journal of the National Cancer Institute, 2002
- EFFECTS OF SAMPLE HANDLING ON THE STABILITY OF INTERLEUKIN 6, TUMOUR NECROSIS FACTOR-α AND LEPTINCytokine, 2000
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Alcohol, Height, and Adiposity in Relation to Estrogen and Prolactin Levels in Postmenopausal WomenJNCI Journal of the National Cancer Institute, 1995
- The assessment of methods of measurementStatistics in Medicine, 1990
- Correction of logistic regression relative risk estimates and confidence intervals for systematic within‐person measurement errorStatistics in Medicine, 1989